Equities

SINTX Technologies Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

SINTX Technologies Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)3.04
  • Today's Change0.315 / 11.58%
  • Shares traded26.27k
  • 1 Year change+2.19%
  • Beta0.6544
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.

  • Revenue in USD (TTM)1.27m
  • Net income in USD-16.56m
  • Incorporated1996
  • Employees20.00
  • Location
    SINTX Technologies Inc1885 West 2100 StreetSALT LAKE CITY 84119United StatesUSA
  • Phone+1 (801) 839-3516
  • Fax+1 (801) 839-3605
  • Websitehttps://sintx.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
AccuStem Sciences Inc0.00-1.61m8.95m2.00---------0.1163-0.11630.00-0.18110.00----0.00-192.46--------------------------26.60------
HeartSciences Inc8.67k-9.04m9.53m15.00--2.20--1,099.73-6.95-6.950.00571.360.00130.0056--578.00-131.22-145.78-202.97-316.2157.9056.93-104,225.80-42,610.782.00-10.000.1068---76.61-41.63-32.70--21.46--
Movano Inc500.00k-17.05m9.83m32.00------19.65-6.54-6.540.0883-2.040.04850.82163.5115,625.00-165.32-159.40-360.23-208.33-270.20---3,409.60-11,662.690.3451-12.462.32------18.97---9.25--
Bioelectronics Corp1.61m-289.82k9.88m9.00------6.14-0.00002-0.000020.00007-0.00066.329.2014.53---113.86-383.59----49.4351.48-18.01-143.480.0099-0.4909----94.01-5.0975.01------
BioRegenx Inc1.93m-18.93m10.00m5.00------5.19-0.0195-0.01950.002-0.00380.20833.1547.03385,874.00-204.29---341.72--78.14---980.96--0.0416-8.01-----31.40---540.38------
PAVmed Inc29.00k-595.00k10.40m39.0028.2428.50--358.78-0.6822-0.68220.00051.550.0009--3.05743.594.17-115.648.14-8,726.29-520.69--4,931.04-3,891.34----0.2111--22.15--148.24--15.12--
QHSLab Inc2.61m-386.75k10.85m4.00------4.15-0.0373-0.03730.1997-0.05421.4926.3812.80653,480.00-22.10-39.97---284.7966.3755.22-14.80-44.620.17140.30381.63--51.31--44.65------
Beyond Air Inc5.80m-36.70m11.06m61.00--0.6605--1.91-7.54-7.541.151.590.13822.608.0195,114.76-89.86-81.28-105.60-103.40-6.70---650.33-4,167.723.73-16.500.4351--219.6721.6622.60--166.66--
REMSleep Holdings Inc12.27k-3.01m11.15m6.00--46.21--908.37-0.0019-0.00190.000010.00020.01930.8251.51---472.04-107.16-671.87-177.2194.87---24,509.54-1,456.221.73--0.2146---42.47--39.36--5.18--
BioNano Genomics Inc28.72m-38.59m11.19m98.00--0.2149--0.3898-737.92-737.929.995.120.34511.455.84293,061.20-46.37-58.31-69.84-72.5345.9718.60-134.36-487.421.82--0.07---14.7924.8951.82--11.02--
SINTX Technologies Inc1.27m-16.56m11.69m20.00--2.70--9.21-6.93-6.930.58941.130.11211.345.5263,500.00-86.86-51.41-121.23-64.3452.0566.36-775.12-575.951.60-302.730.0143--9.9033.18-33.06--36.24--
Vicarious Surgical Inc0.00-53.59m12.95m123.00--0.7699-----9.04-9.040.002.360.00----0.00-97.47-35.33-109.17-37.33------------0.00------11.04---6.06--
Trinity Biotech PLC (ADR)49.41m-35.91m14.22m401.00------0.2878-2.19-2.223.19-2.570.50941.523.48123,217.00-37.02-23.08-52.54-35.9733.8138.51-72.67-32.840.4083-1.731.79--8.31-7.4115.33---3.22--
Vivos Therapeutics Inc17.32m-17.10m14.35m109.00--4.96--0.8284-1.88-1.881.930.30630.8449--13.38158,871.60-83.45-85.27-120.33-138.5155.7467.27-98.77-108.16----0.7785--8.915.7018.02--26.46--
Phaos Technlgy Hldngs (Cayman) Limited132.98k-100.00bn14.53m--------109.26-------0.0605------------------------0.3176------------------
Data as of Feb 13 2026. Currency figures normalised to SINTX Technologies Inc's reporting currency: US Dollar USD

Institutional shareholders

7.70%Per cent of shares held by top holders
HolderShares% Held
DRW Securities LLCas of 31 Dec 202590.39k2.35%
Veracity Capital LLCas of 31 Dec 202576.67k1.99%
Geode Capital Management LLCas of 31 Dec 202526.62k0.69%
Vanguard Fiduciary Trust Co.as of 31 Dec 202523.53k0.61%
The Vanguard Group, Inc.as of 31 Dec 202520.91k0.54%
Citadel Securities LLCas of 30 Sep 202513.49k0.35%
SSgA Funds Management, Inc.as of 31 Dec 202513.30k0.35%
UBS Securities LLCas of 31 Dec 202511.74k0.31%
Broadway Wealth Solutions, Inc.as of 31 Dec 202510.00k0.26%
Virtus Wealth Solutionsas of 31 Dec 202510.00k0.26%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.